Pharmanutra S.p.A.
PHN.MI · MIL
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | €371 | €443 | €484 | €523 |
| - Cash | €15 | €9 | €24 | €16 |
| + Debt | €21 | €22 | €24 | €24 |
| Enterprise Value | €378 | €456 | €484 | €532 |
| Revenue | €33 | €36 | €27 | €32 |
| % Growth | -10.2% | 35.7% | -17.2% | – |
| Gross Profit | €25 | €29 | €21 | €32 |
| % Margin | 76.6% | 80.6% | 77.5% | 99% |
| EBITDA | €9 | €12 | €5 | €8 |
| % Margin | 27% | 31.8% | 18.9% | 25.3% |
| Net Income | €5 | €7 | €2 | €3 |
| % Margin | 14.8% | 18.6% | 9.1% | 10.7% |
| EPS Diluted | 0.51 | 0.72 | 0.25 | 0.36 |
| % Growth | -29.2% | 188% | -30.6% | – |
| Operating Cash Flow | €8 | -€2 | €2 | €6 |
| Capital Expenditures | -€1 | -€1 | -€1 | -€2 |
| Free Cash Flow | €8 | -€3 | €1 | €5 |